Prevention of Bacterial Infection in Neutropenic Patients with Hematologic Malignancies
Journal: Annals of Internal Medicine (1991)

Articles1 July 1991Prevention of Bacterial Infection in Neutropenic Patients with Hematologic MalignanciesA Randomized, Multicenter Trial Comparing Norfloxacin with CiprofloxacinAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-115-1-7 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractAbstractObjective: To compare the efficacy of norfloxacin and ciprofloxacin in preventing bacterial infection in neutropenic patients.Design: A randomized, controlled, multicenter trial.Setting: Twenty-one hematologic units in tertiary care or university hospitals.Patients: Eight hundred and one consecutive, afebrile, adult patients who had hematologic malignancies or who had bone marrow transplantation and chemotherapy-induced neutropenia (neutrophil count, < 1000/mm3) expected to last more than 10 days.Intervention: Patients were randomly assigned to receive orally every 12 hours norfloxacin, 400 mg, or ciprofloxacin, 500 mg.Measurements: Efficacy analysis was done for 619 patients: 319 treated with norfloxacin and 300 treated with ciprofloxacin.Main Results: More patients receiving ciprofloxacin did not develop fever during neutropenia and did not receive antibiotics (34%) compared with those receiving norfloxacin (25%) (P = 0.01). Patients receiving ciprofloxacin had a lower rate of microbiologically documented infection (17% compared with 24%; P = 0.058), particularly of infection from gram-negative bacilli (4% compared with 9%; P = 0.03). The interval to the first febrile episode was also longer in patients receiving ciprofloxacin (8.3 compared with 7.2 days; P = 0.055). The rates of clinically documented infection, fever of unknown origin, and mortality as well as compliance and tolerability were similar in the two groups. Patients who had neutropenia for less than 15 days, who had severe neutropenia for less than 7 days, and who received antifungal prophylaxis benefited most from ciprofloxacin therapy.Conclusion: Ciprofloxacin should be used to prevent the development of infection in neutropenic patients with hematologic malignancies.References1. Young L. Antimicrobial prophylaxis against infection in neutropenic patients [Editorial]. J Infect Dis. 1983;147:611-4. CrossrefMedlineGoogle Scholar2. Schimpff S. Infection prevention during profound granulocytopenia: new approaches to alimentary canal microbial suppression. Ann Intern Med. 1980;93:358-61. LinkGoogle Scholar3. Henry S. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients. Am J Med. 1984;76:645-51. CrossrefMedlineGoogle Scholar4. MartinoVendittiPettiMandelliSerra PMMFP. Cotrimoxazole prophylaxis in patients with leukemia and prolonged granulocytopenia. Am J Med Sci. 1984;287:7-9. CrossrefMedlineGoogle Scholar5. Young L. Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspective for the future. Eur J Clin Microbiol Infect Dis. 1988;7:93-7. CrossrefMedlineGoogle Scholar6. KarpMerzHendricksen JWC. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1987;106:1-7. LinkGoogle Scholar7. CasaliVerriPaoletti ACG. Chemoprophylaxis of bacterial infections in granulocytopenic cancer patients using norfloxacin. Chemioterapia. 1988;7:327-9. MedlineGoogle Scholar8. Hartlapp J. Antimicrobial prophylaxis in immunocompromised patients. Drugs. 1987;34(Suppl 1):131-3. MedlineGoogle Scholar9. BowRaynerLouie EET. Comparison of norfloxacin with co-trimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. Am J Med. 1988;84:847-54. CrossrefMedlineGoogle Scholar10. DekkerRozenberg-ArskaVerhoef AMJ. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med. 1987;106:7-11. LinkGoogle Scholar11. CrucianiConciaNavarra MEA. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children—perspective randomized study. Infection. 1989;17:65-9. CrossrefMedlineGoogle Scholar12. LiangYungChan RRT. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. Antimicrob Agents Chemother. 1990;34:215-8. CrossrefMedlineGoogle Scholar13. WinstonHoNakaoGalewChamplin DWSRR. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med. 1986;80:884-90. CrossrefMedlineGoogle Scholar14. WinstonHoBrucknerGaleChamplin DWDRR. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med. 1990;88:36-42. CrossrefMedlineGoogle Scholar15. MenichettiFeliciniBucaneve FRG. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1989;4:489-92. MedlineGoogle Scholar16. Young L. The new fluorinated quinolones for infection prevention in acute leukemia [Editorial]. Ann Intern Med. 1987;106:144-6. LinkGoogle Scholar17. . GIMEMA ALL 0183: a multicentric study on adult acute lymphoblastic leukemia. The 1990 update. Blood 1990; 76(Suppl 1). Proceedings of the International Society of Hematology XXIII Congress and of the American Society of Hematology XXXII Annual Meeting. Abstract 1248. Google Scholar18. . Allogenic versus autologous BMT versus intensive consolidation in acute myelogenous leukemia in first remission. An EORTC/GIMEMA phase III trial (LAM 8A). Blood. 1990; 76(Suppl 1). Proceedings of the International Society of Hematology XXIII Congress and of the American Society of Hematology XXXII Annual Meeting. Abstract 1349. Google Scholar19. BauerKirbySherrisTurck AWJH. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45:493-6. CrossrefMedlineGoogle Scholar20. GayaKlasterskySchimpffTattersall HJSM. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease. Eur J Cancer. 1975;11(Suppl):1-4. MedlineGoogle Scholar21. VendittiSantiniSerraMicozziGentileMartino MCPAGP. Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production. Antimicrob Agents Chemother. 1989;33:209-11. CrossrefMedlineGoogle Scholar22. Courvalin P. Plasmid-mediated 4-quinolone resistance: a real or apparent absence? Antimicrob Agents Chemother. 1990;34:681-4. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto. For participating investigators and institutions, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAntibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyBacterial InfectionsQuinolonesEvaluation of Prophylaxis with Norfloxacin and Ceftriaxone versus Ciprofloxacin during the Period of Neutropenia after Haematopoietic Stem Cell Transplantation: Retrospective Analysis of Two Sequencial CohortsCombined dysfunctions of immune cells predict nosocomial infection in critically ill patientsHyperinflammation and Mediators of Immune Suppression in Critical IllnessCiprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) – a single-center experienceInfection probability score, APACHE II and KARNOFSKY scoring systems as predictors of infection onset in haematology-oncology patientsQuinolonesProphylaxis and Empirical Therapy of Infection in Cancer PatientsInfections associated with neutropenia and transplantationBarrier precautions, prophylaxis and neutropenic feverAntibiotic prophylaxis for patients with acute leukemiaQuinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patientsEmergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxisAntibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyLevofloxacin to Prevent Bacterial Infection in Patients with Cancer and NeutropeniaMeta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic PatientsAnat Gafter-Gvili, MD, Abigail Fraser, MPH, Mical Paul, MD, and Leonard Leibovici, MDDifferences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centresFootwear Exchange Has No Influence on the Incidence of Febrile Neutropenia in Patients Undergoing Chemotherapy for Hematologic MalignanciesIn vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patientsA multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancerThe role of fluoroquinolones in the therapy and prophylaxis of neutropenic patients with cancerGastrointestinal and intraabdominal infectionsAntimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patientsTreatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized studyManagement of Infections in Leukemia and LymphomaOral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistanceIntegrating Fluoroquinolones into the Hospital FormularyBacteremia Due to Quinolone‐Resistant Escherichia coli in a Teaching Hospital in South KoreaINFECTIONS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATIONBacteremia Due to Stenotrophomonas maltophilia in Patients with Hematologic MalignanciesUse of the Quinolones in Immunocompromised PatientsThe prophylaxis of bacterial infections in neutropenic patientsEPIDEMIOLOGY AND RISK FACTORS FOR NOSOCOMIAL PNUEMONIAComparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibioticsReflections on gut decontamination in hematologyMolecular typing of fluoroquinolone-resistant and fluoroquinolone-susceptible Escherichia coli isolated from blood of neutropenic cancer patients in a single centerAntimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centersThe Prevention of Ventilator-Associated PneumoniaPlanned progressive antimicrobial therapy in neutropenic patientsEmergence and infectious complications of ciprofloxacin-resistantEscherichia coli in haematological cancer patientsClinical Use of QuinolonesPREVENTION OF INFECTIONS IN BONE MARROW TRANSPLANT RECIPIENTSEmpirical antibacterial treatment for sepsis and the role of glycopeptides: recommendations from a European panelLack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplantsChemotherapy-induced neutropenia and fever in patients with metastatic breast carcinoma receiving salvage chemotherapyUse of fluoroquinolones as prophylactic agents in patients with neutropeniaThe Influence of Antimicrobial Prophylaxis on the Microbial and Clinical Findings in Patients after Autologous Bone Marrow TransplantationProphylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescueTreatment and Control of Colonization in the Prevention of Nosocomial InfectionsTreatment and Control of Colonization in the Prevention of Nosocomial InfectionsEmergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxisINFECTION IN THE BONE MARROW TRANSPLANT RECIPIENTConcentration of pefloxacin in feces during infection prophylaxis in neutropenic patientsFactors predisposing cancer patients to infectionChemoprophylaxis for the prevention of bacterial and fungal infectionsQuinolonesIntérêt du rHuG-CSF en péri-opératoire dans une neutropénie sévère post-chimiothérapieInfection in immunocompromised patients with malignant blood disorders in a district general hospitalEffects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection ProgramAntibiotic strategy in orofacial/head and neck infections in severe neutropeniaEmergence of fluoroquinolone-resistant Escherichia coli at a cancer centerInfections in cancer patients: some controversial issuesA randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxisManagement of Infections in Leukemia and LymphomaFluoroquinolones for Infection Prevention After Bone Marrow TransplantationFactors associated with bacteraemia in febrile, granulocytopenic cancer patientsChemotherapy for germ cell tumours: Prophylactic ciprofloxacin reduces the incidence of neutropenic feverRecent advances in the management of infections in cancer patientsCritical Appraisal of Antimicrobials for Prevention of Infections in Immunocompromised HostsL'amikacine en dose unique journalière dans le traitement probabiliste du patient neutropénique fébrile : justification, efficacité et toléranceThe Antimicrobial ArmamentariumNosocomial outbreak of severe Pseudomonas aeruginosa infections in haematological patientsCiprofloxacin-induced neutropenia and erythema multiformeInfectious Complications During AutotransplantationEnterococcal septicemia in patients with hematological malignanciesChemoprophylaxis of Bacterial Infections in Granulocytopenic Patients with Ciprofloxacin vs Ciprofloxacin plus AmoxicillinInfections in Patients with Acute Non-Lymphocytic Leukemia Nursed with Central or Peripheral Venous AccessOral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study GroupThe new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patientsBone Marrow Transplantation: A ReviewSelective decontamination in neutropenic patientsGram-Positive Bacteremias in Neutropenic PatientsThe Use of Glycopeptides as Empiric Antibiotic Therapy in Febrile Neutropenic Patients: A Comparison Between Teicoplanin (TEI) and Vancomycin (VAN)Quinolone Prophylaxis during NeutropeniaP. H. Chandrasekar, MDNewsPrevention of infection in immunocompromised hosts 1 July 1991Volume 115, Issue 1Page: 7-12KeywordsAntibioticsAntifungalsBone marrow transplantationFever of unknown originFeversHematologic malignanciesMortalityNeutropeniaNeutrophilsProphylaxis ePublished: 1 December 2008 Issue Published: 1 July 1991 Copyright & Permissions© 1991 American College of PhysiciansPDF downloadLoading ...